[go: up one dir, main page]

WO2000050048A3 - Transplantation de moelle osseuse pour la regeneration et la reparation hepatique - Google Patents

Transplantation de moelle osseuse pour la regeneration et la reparation hepatique Download PDF

Info

Publication number
WO2000050048A3
WO2000050048A3 PCT/US2000/004744 US0004744W WO0050048A3 WO 2000050048 A3 WO2000050048 A3 WO 2000050048A3 US 0004744 W US0004744 W US 0004744W WO 0050048 A3 WO0050048 A3 WO 0050048A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
hepatic
liver regeneration
bone marrow
oval
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/004744
Other languages
English (en)
Other versions
WO2000050048A2 (fr
WO2000050048A9 (fr
Inventor
Bryon E Petersen
Julie P Goff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Priority to AU33763/00A priority Critical patent/AU3376300A/en
Priority to EP00911954A priority patent/EP1154780A2/fr
Priority to CA002366707A priority patent/CA2366707A1/fr
Publication of WO2000050048A2 publication Critical patent/WO2000050048A2/fr
Publication of WO2000050048A3 publication Critical patent/WO2000050048A3/fr
Anticipated expiration legal-status Critical
Publication of WO2000050048A9 publication Critical patent/WO2000050048A9/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur des procédés et des compositions permettant de stimuler la régénération du foie chez des sujets souffrant de troubles du foie. Plus particulièrement, les procédés et les compositions décrits dans la présente invention sont utiles pour la transplantation de cellules de moelle osseuse sur un hôte receveur en quantités suffisantes pour permettre la production d'hépatocytes, de cellules biliaires canalaires et de cellules ovales pendant la régénération du foie. Cette invention est basée sur le constat selon lequel les cellules dérivées de la moelle osseuse peuvent jouer un rôle actif dans la production d'hépatocytes, de cellules biliaires canalaires et de cellules ovales pendant la régénération du foie. En outre, cette invention porte sur des procédés utilisés pour dériver des populations enrichies de cellules ovales hépatiques, considérées comme étant des cellules souches hépatiques, à l'aide d'anticorps capables de reconnaître l'antigène de surface cellulaire Thy-1 exprimé à la surface des cellules ovales hépatiques. On peut transplanter les populations enrichies de cellules ovales hépatiques sur un hôte afin de stimuler la régénération du foie chez les sujets souffrant de troubles du foie.
PCT/US2000/004744 1999-02-26 2000-02-25 Transplantation de moelle osseuse pour la regeneration et la reparation hepatique Ceased WO2000050048A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU33763/00A AU3376300A (en) 1999-02-26 2000-02-25 Bone marrow transplantation for hepatic regeneration and repair
EP00911954A EP1154780A2 (fr) 1999-02-26 2000-02-25 Transplantation de moelle osseuse pour la regeneration et la reparation hepatique
CA002366707A CA2366707A1 (fr) 1999-02-26 2000-02-25 Transplantation de moelle osseuse pour la regeneration et la reparation hepatique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12225099P 1999-02-26 1999-02-26
US60/122,250 1999-03-03

Publications (3)

Publication Number Publication Date
WO2000050048A2 WO2000050048A2 (fr) 2000-08-31
WO2000050048A3 true WO2000050048A3 (fr) 2001-02-01
WO2000050048A9 WO2000050048A9 (fr) 2002-03-14

Family

ID=22401591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/004744 Ceased WO2000050048A2 (fr) 1999-02-26 2000-02-25 Transplantation de moelle osseuse pour la regeneration et la reparation hepatique

Country Status (4)

Country Link
EP (1) EP1154780A2 (fr)
AU (1) AU3376300A (fr)
CA (1) CA2366707A1 (fr)
WO (1) WO2000050048A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569471B2 (en) 2003-08-11 2013-10-29 University Of South Florida Stem cell beacon

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082152A1 (en) 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US7256042B2 (en) 2000-04-27 2007-08-14 Geron Corporation Process for making hepatocytes from pluripotent stem cells
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
US7282366B2 (en) 2000-04-27 2007-10-16 Geron Corporation Hepatocytes for therapy and drug screening made from embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US20040063204A1 (en) * 2002-08-14 2004-04-01 Lijun Yang Bone marrow cell differentiation
AU2003277205A1 (en) * 2002-10-02 2004-04-23 New York University Adult bone marrow derived stem cells
US7169608B2 (en) 2002-10-18 2007-01-30 University Of Florida Research Foundation, Inc. Bone marrow cell differentiation
EP1622609A4 (fr) * 2003-04-29 2008-09-03 Smithkline Beecham Corp Procedes de traitement de maladies/lesions degeneratives
CA2457296A1 (fr) 2003-08-19 2005-02-19 Takahiro Ochiya Methodes favorisant la differenciation de cellules pluripotentes
JP4563705B2 (ja) * 2004-03-19 2010-10-13 グンゼ株式会社 胆管組織再生用基材
GB2453074B (en) 2006-06-02 2011-06-22 Geron Corp Differentiation of primate pluripotent cells to hepatocyte-lineage cells
EP2142206B1 (fr) 2007-03-30 2014-07-30 The Cleveland Clinic Foundation SDF-1 pour son utilisation dans le traitement des troubles vasculaires ischémiques périphériques
AU2008338525B2 (en) 2007-12-14 2015-04-02 Juventas Therapeutics, Inc. Compositions and methods of promoting wound healing
AU2010286511B2 (en) 2009-08-28 2016-05-26 Juventas Therapeutics, Inc. SDF-1 delivery for treating ischemic tissue

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018972A1 (fr) * 1990-05-30 1991-12-12 Cellco, Inc. Culture de cellules de moelle osseuse utilisees en immunotherapie adoptive
US5789246A (en) * 1991-08-07 1998-08-04 Albert Einstein College Of Medicine Compositions comprising hepatocyte precursors
WO1999039743A2 (fr) * 1998-02-09 1999-08-12 University Of Southern California Procede de stimulation de la proliferation des cellules hepatiques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018972A1 (fr) * 1990-05-30 1991-12-12 Cellco, Inc. Culture de cellules de moelle osseuse utilisees en immunotherapie adoptive
US5789246A (en) * 1991-08-07 1998-08-04 Albert Einstein College Of Medicine Compositions comprising hepatocyte precursors
WO1999039743A2 (fr) * 1998-02-09 1999-08-12 University Of Southern California Procede de stimulation de la proliferation des cellules hepatiques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALISON MALCOLM ET AL: "Wound healing in the liver with particular reference to stem cells.", PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON B BIOLOGICAL, vol. 353, no. 1370, 29 June 1998 (1998-06-29), June 29, 1998, pages 877 - 894, XP000946107, ISSN: 0962-8436 *
PETERSEN B E ET AL: "Bone marrow as a potential source of hepatic oval cells.", SCIENCE (WASHINGTON D C), vol. 284, no. 5417, 14 May 1999 (1999-05-14), pages 1168 - 1170, XP002147735, ISSN: 0036-8075 *
PETERSEN BRYON E ET AL: "Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat.", HEPATOLOGY, vol. 27, no. 2, February 1998 (1998-02-01), pages 433 - 445, XP000946076, ISSN: 0270-9139 *
PETERSEN BRYON E ET AL: "Thy-1+ sorted hepatic oval cells in culture maintain oval cell phenotypic markers.", FASEB JOURNAL, vol. 12, no. 4, 17 March 1998 (1998-03-17), pages A468, XP002147734, ISSN: 0892-6638 *
YASUI OUKI ET AL: "Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver.", HEPATOLOGY, vol. 25, no. 2, 1997, pages 329 - 334, XP000946193, ISSN: 0270-9139 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569471B2 (en) 2003-08-11 2013-10-29 University Of South Florida Stem cell beacon
US9040676B2 (en) 2003-08-11 2015-05-26 University Of South Florida Vigilant cells

Also Published As

Publication number Publication date
WO2000050048A2 (fr) 2000-08-31
AU3376300A (en) 2000-09-14
EP1154780A2 (fr) 2001-11-21
WO2000050048A9 (fr) 2002-03-14
CA2366707A1 (fr) 2000-08-31

Similar Documents

Publication Publication Date Title
WO2000050048A3 (fr) Transplantation de moelle osseuse pour la regeneration et la reparation hepatique
GB2427874A (en) Differentiation of stem cells to endoderm and pancreatic lineage
EP2292736B1 (fr) Identification et isolation de cellules multipotentes issues du tissu mésenchymateux non ostéochondral
WO2004069172A3 (fr) Cellules inductibles par multilignees et leurs utilisations
US20090029463A1 (en) Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
EP2471906A3 (fr) Populations de cellules souches placentaires
WO2001021767A3 (fr) Cellules souches embryonnaires totipotentes
IL210618A0 (en) Population of multipotent adult stem cells expressing telomerase and being cd45- and glycophorin a-, methods for their preparation and uses
WO2003014313A3 (fr) Compositions et procedes de substitution pour la culture de cellules souches
GB2392674A (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
WO2005047524A3 (fr) Compositions et procedes pour induire la differenciation cellulaire
WO2005017117A3 (fr) Cellules souches foetales amniotiques pluripotentes (mafsc) et constitution de banques de celles-ci
EP1077254A3 (fr) Potentialités de différenciation en multiples lignées cellulaires mésodermiques pour des cellules de stroma dérivées de tissu adipeux et leurs applications
WO2009057537A1 (fr) Composition pharmaceutique contenant des cellules-souches mésenchymateuses humaines
GB2427873A (en) Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
WO2007147004A2 (fr) Différentiation de cellules progénitrices de lignées multiples en hépatocytes
ATE324030T1 (de) Brassica-transformation durch teilchenbeschuss
WO2005097979A3 (fr) Procedes et compositions destines a l'obtention de cellules souches hematopoietiques derivees de cellules souches embryonnaires et utilisations
WO2006047743A8 (fr) Cellules souches adultes de porc
CA2450789A1 (fr) Cellules de schwann provenant de cellules myeloides interstitielles
Issaragrisil Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells
WO2004015091A3 (fr) Preparation de pneumocytes de type ii a partir de cellules souches
WO2006042197A3 (fr) Utilisation de del-1 dans une regeneration de cheveux, d'os et de cartilage
DE60330223D1 (fr)
JP2003235548A5 (fr)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2366707

Country of ref document: CA

Ref country code: CA

Ref document number: 2366707

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000911954

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000911954

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09914175

Country of ref document: US

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/28-28/28, DRAWINGS, REPLACED BY NEW PAGES 1/28-28/28

WWW Wipo information: withdrawn in national office

Ref document number: 2000911954

Country of ref document: EP